MARKET WIREYahoo Finance • 23h ago
Fortrea (FTRE) Stock Trades Up, Here Is WhyYahoo Finance report covering Fortrea Holdings Inc. (FTRE) market action, institutional positioning, and fundamental catalysts.
Why FTRE Stock dropped -5.96% Today — RQD Quant Desk Flash
$20.02 -5.96% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $19.77
Fortrea Holdings Inc. (FTRE) carries a Roarable Rating of E (Strong Sell) with 32/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE E • RED ALERT
Cap $2.05B
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER
Click Any Pre-Computed AI Quant Specialist Briefing on FTRE Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is FTRE stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-03, Fortrea Holdings Inc. (NASDAQ: FTRE) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 32/100 at a spot price of $20.02 (-5.96% 1D, market cap $2.05B). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 14/20, SEC Balance-Sheet Forensics 5/20, FRED Macro Regime Fit 6/20, and Executive Insider Alignment 3/20. Across 1015 tracked Health Care issuers, FTRE ranks #711 in composite RQD confidence.
✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does FTRE compare to CLOV and PSNL in the Health Care sector?
▼
Within the Health Care sector (Medical Specialities), FTRE carries a Roarable E (32/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -35.0%. By comparison, CLOV (Clover Health Investments Corp. (Class A)) holds a D- grade (36/100 RQD, P/E N/A, ROIC -29.3%, cap $2.37B) and PSNL (Personalis Inc.) posts a D- grade (36/100 RQD, P/E N/A, ROIC -35.0%, cap $1.69B). Among the 5-stock peer group, FTRE leads on earnings multiple (N/A) while ALHC leads on capital efficiency (13.9% ROIC).
✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for FTRE?
▼
Per FTRE's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001965040), Fortrea Holdings Inc. generated $2.72B in revenue (+1.0% YoY), -$989.0M in net income, and -$9.1M in free cash flow against $2.72B in total assets and $1.05B in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.
✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $19.77 (-1.26%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 4/20 (E) • 0% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record Warning: Scores below 50 (32/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-9.2% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERRED ALERT • E
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw D- · Rk E
Each axis scored 0–20
12M PRICE TARGET CONE-11.7% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for FTRE)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (32/100 Composite)
🔍 WHY FTRE SCORES 32/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Whale & Options Positioning+14/20 pts (44% of score)
20D Institutional Volume Accumulation (±12.5% realized swing band)
▲ #2 Bullish Driver: Macro Regime Fit+6/20 pts (19% of score)
FRED Regime × Technicals: 65% of 52W Range • RSI-14 at 46.4 (NEUTRAL RANGE)
▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)
Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade D$21.34+12.7% Next Q
40
Q2 (-2Q)Grade E$24.06+7.6% Next Q
37
Q3 (-1Q)Grade E$25.88-22.6% Next Q
35
CurrentGrade E$20.02-9.2% Hist 90D α
32
Trajectory: D (40) → E (32)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER
⚔️ Adversarial Opposing Case: What Could Spark a FTRE Turnaround Squeeze
While FTRE currently carries a cautious 32/100 (E) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
🚀 Contrarian Squeeze Trigger #1
Established market leader in Health Care with deep daily trading liquidity.
🚀 Contrarian Squeeze Trigger #2
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($20.53) and Max Pain ($21.02) forces dealer call-delta covering toward $27.47.
🚀 Contrarian Squeeze Trigger #3
Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
🎲 LIVE PREDICTION MARKET ODDS TIED TO $FTRE• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “FTRE Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why FTRE Stock dropped -5.96% Today — RQD Quant Desk Flash
Fortrea Holdings Inc. (FTRE) dropped -5.96% to $20.02, trading at 65% of its 52-week range ($8.55 – $26.16). Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 65% of its 52-week range ($8.55 – $26.16) with RSI-14 at 46.4 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $20.02 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable E (Strong Sell) backed by 52% gross margin and $0 annual free cash flow.
Live FTRE Headlines & Catalysts
MARKET WIREYahoo Finance • 1d ago
Is Fortrea Holdings (FTRE) Still Cheap After Its 116% Run?Yahoo Finance report covering Fortrea Holdings Inc. (FTRE) market action, institutional positioning, and fundamental catalysts.
CATALYSTGuruFocus • 1d ago
Barclays Raises Fortrea (FTRE) Price Target to $26 Amid Stock PrGuruFocus report covering Fortrea Holdings Inc. (FTRE) market action, institutional positioning, and fundamental catalysts.
MARKET WIRESeeking Alpha • 1d ago
Fortrea Holdings Inc. 2026 Q3 - Results - Earnings Call Presentation (NASDAQ:FTRE) 2026-10-29Seeking Alpha report covering Fortrea Holdings Inc. (FTRE) market action, institutional positioning, and fundamental catalysts.
MARKET WIRETradingView • 1d ago
Fortrea Holdings Inc. Estimates – NASDAQ:FTRETradingView report covering Fortrea Holdings Inc. (FTRE) market action, institutional positioning, and fundamental catalysts.
MARKET WIREYahoo Finance • 1d ago
Fortrea Holdings (FTRE) Stock Sees Modest Fair Value Lift As Margin Views ImproveYahoo Finance report covering Fortrea Holdings Inc. (FTRE) market action, institutional positioning, and fundamental catalysts.
RISK WATCHYahoo Finance • 1d ago
Fortrea (FTRE) Stock Drops After Q3 Results Lift GuidanceYahoo Finance report covering Fortrea Holdings Inc. (FTRE) market action, institutional positioning, and fundamental catalysts.
MARKET WIREYahoo Finance • 1d ago
Earnings to watch: Fortrea (FTRE) reports Q3 results tomorrowYahoo Finance report covering Fortrea Holdings Inc. (FTRE) market action, institutional positioning, and fundamental catalysts.
CATALYSTYahoo • 2d ago
FTRE Q3 deep dive: margin gains, backlog reset, and early-phase expansion shape outlookClinical research company Fortrea Holdings (NASDAQ:FTRE) reported Q3 2026 results beating Wall Street’s revenue expectations, but sales fell by 1.4% year on year to $691.5 million. The company’s full-year revenue guidanc
CATALYSTYahoo • 3d ago
Earnings Beat Could Reset The Case For Fortrea StockFortrea Holdings reported Q3 2026 revenue of US$691.5 million and returned to a modest profit, while also narrowing and raising full year 2026 revenue guidance to a range of US$2.665 billion to US$2.69 billion. The acqui
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring FTRE)
- ✓Walkthrough of FTRE's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
FTRE // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +63.43%▲ ASCENDING CHANNEL
2026-11-03O $23.13H $23.13L $20.02C $20.02VOL 2.87M
RES: $26.53SUP: $17.67SMA50: $20.53SMA200: $15.79
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
FTRE Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle
22.3%/yr Implied 5Y Growth
vs. +1.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger
No active Ellis Vennor swing setup published on FTRE today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for FTRE. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for FTRE today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (FTRE)
Health Care Rank #711 of 1015
⚔️ CLOV vs FTRE Full Matrix →
1. Head-to-Head Health Care Peer Comparison (FTRE vs. CLOV, PSNL, ALHC, ACHC)
Industry: Medical Specialities (41 Tracked Issuers)Across 1015 tracked Health Care securities in the Roarable RQD universe, Fortrea Holdings Inc. (FTRE) ranks #711 by composite RQD confidence (32/100, grade E) and #249 by equity capitalization ($2.05B). Within this direct 5-issuer industry benchmark cohort, FTRE leads on earnings valuation at N/A trailing P/E, while ALHC leads on capital efficiency and profitability with 13.9% ROIC and — gross margin. ALHC currently holds the highest overall quantitative score in the immediate peer group at 56/100 (D+) compared with FTRE at 32/100 (E).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| FTRE
ACTIVE
Fortrea Holdings Inc. | E | 32/100 | — | — | -35.0% | -5.96% | $2.05B | Benchmark Subject |
| CLOV Clover Health Investments Corp. (Class A) | D- | 36/100 | — | — | -29.3% | -3.36% | $2.37B | /clov-vs-ftre → |
| PSNL Personalis Inc. | D- | 36/100 | — | 22.7% | -35.0% | -0.38% | $1.69B | /psnl-vs-ftre → |
| ALHC Alignment Healthcare Inc. | D+ | 56/100 | — | — | 13.9% | -3.71% | $1.52B | /alhc-vs-ftre → |
| ACHC Acadia Healthcare Company Inc. | D- | 38/100 | — | — | -24.8% | -1.13% | $2.79B | /achc-vs-ftre → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001965040 ↗In its most recent audited fiscal period (FY2025, filed 2025-12-31), Fortrea Holdings Inc. (FTRE) reported GAAP revenue of $2.72B (+1.0% vs. FY2024 revenue of $2.70B , and -4.2% cumulative change since FY2023) , GAAP net income of -$989.0M, operating cash flow of $113.5M, and free cash flow of -$9.1M (-106.4% YoY). On the balance sheet, FTRE closed FY2025 with $2.72B in total assets against $1.05B in total debt (Altman Z-Score: 0.45, Piotroski F-Score: 3/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $2.72B | -$989.0M | $113.5M | -$9.1M | $2.72B | $1.05B |
| FY2024 (FY) | 2024-12-31 | $2.70B | -$329.0M | $262.8M | $141.5M | $3.58B | $1.05B |
| FY2023 (FY) | 2023-12-31 | $2.84B | -$25.0M | $168.4M | $40.5M | $3.41B | $798.2M |
3. FTRE Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs FTRE stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-03, Fortrea Holdings Inc. (NASDAQ: FTRE) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 32/100 at a spot price of $20.02 (-5.96% 1D, market cap $2.05B). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 14/20, SEC Balance-Sheet Forensics 5/20, FRED Macro Regime Fit 6/20, and Executive Insider Alignment 3/20. Across 1015 tracked Health Care issuers, FTRE ranks #711 in composite RQD confidence.
How does FTRE compare to CLOV and PSNL in the Health Care sector?
Within the Health Care sector (Medical Specialities), FTRE carries a Roarable E (32/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -35.0%. By comparison, CLOV (Clover Health Investments Corp. (Class A)) holds a D- grade (36/100 RQD, P/E N/A, ROIC -29.3%, cap $2.37B) and PSNL (Personalis Inc.) posts a D- grade (36/100 RQD, P/E N/A, ROIC -35.0%, cap $1.69B). Among the 5-stock peer group, FTRE leads on earnings multiple (N/A) while ALHC leads on capital efficiency (13.9% ROIC).
What are the biggest fundamental strengths and SEC risk factors for FTRE?
Per FTRE's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001965040), Fortrea Holdings Inc. generated $2.72B in revenue (+1.0% YoY), -$989.0M in net income, and -$9.1M in free cash flow against $2.72B in total assets and $1.05B in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.
Where is FTRE trading relative to its 50-day, 200-day, and 52-week technical levels?
FTRE last traded at $20.02 (-5.96% on volume of 1,752,222 shares), positioning the stock -2.48% below its 50-day simple moving average ($20.53) and +26.79% above its 200-day simple moving average ($15.79). Across its 52-week range of $8.55 to $26.16, FTRE sits at the 65.1% percentile with a 14-day RSI of 46.4 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($17.52 to $22.52).
ROARABLE RATING BRIEF • RQD 32/100 (E)
✓ SEC XBRL & RQD VERIFIED
FTRE — Fortrea Holdings Inc.: What the Facts Mean to a Prospective Investor
Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2025-12-31
1. Roarable Rating Brief: What This Means to a Prospective Investor
Fortrea Holdings Inc. (FTRE) earns a live Roarable RQD composite score of 32/100, corresponding to a E letter grade (Roarable Strong Sell) at a spot price of $20.02 (-5.96% 1D, market capitalization $2.05B).
- Fundamental Cash Engine (4/20): Anchored by return on invested capital (ROIC) of -35.0%, gross margin of —, operating margin of -32.0%, and free cash flow yield of -0.41%.
- Whale 13F & Options Flow (14/20) + Insider Conviction (3/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
- Macro Regime Fit (6/20) + Forensic Balance Sheet (5/20): Incorporates a 0.99x equity beta, Altman Z-Score of 0.45, Piotroski F-Score of 3/9, and Debt/Equity of 1.86x.
2. Business Model, Unit Margins & SEC Financial Trajectory
Fortrea Holdings Inc. Is a NASDAQ-listed issuer in the Health Care sector and Medical Specialities industry.
In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), Fortrea Holdings Inc. (FTRE) reported $2.72B in annual revenue (up from $2.70B in FY2024, +1.0% YoY) and -$989.0M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($2.84B revenue, -$25.0M net income) through FY2025, FTRE scaled operating cash flow to $113.5M and free cash flow to -$9.1M, backed by $2.72B in total assets against $1.05B in total debt.
3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff
- 🐂 Primary Bull Case (E • RQD 32/100): Established market leader in Health Care with deep daily trading liquidity. Free cash flow yield of -0.41% and institutional whale pillar of 14/20. With Fundamental Cash Engine at 4/20 and Institutional Whale Flow at 14/20, sustained execution supports upside toward the upper end of the $8.55 – $26.16 52-week range.
- 🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against -32.0% operating margins and a 0.99x macro beta.
4. 2nd-Order Butterfly Ripples & Key Questions to Watch
Operating in Medical Specialities (Health Care), FTRE carries a macro regime beta of 0.99 and gross margin of —.
- Key Question #1: Can FTRE sustain or expand its -32.0% operating margin and -35.0% ROIC against Medical Specialities peers over the next 4 quarters?
- Key Question #2: Following FY2025 revenue of $2.72B and free cash flow of -$9.1M, how will capital allocation balance growth reinvestment against $1.05B in total debt?
- Key Question #3: How sensitive is FTRE's 29.0x forward P/E multiple to Health Care capital spending cycles and macro interest-rate shifts (Beta 0.99x)?
FTRE Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for Fortrea Holdings Inc. (FTRE) • Click "Debate This Headline" to argue it in the Roar Pit below
🟡 MARKET WIRE Yahoo Finance • 23h ago
Fortrea (FTRE) Stock Trades Up, Here Is Why Yahoo Finance report covering Fortrea Holdings Inc. (FTRE) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Yahoo Finance • 1d ago
Is Fortrea Holdings (FTRE) Still Cheap After Its 116% Run? Yahoo Finance report covering Fortrea Holdings Inc. (FTRE) market action, institutional positioning, and fundamental catalysts.
🟢 CATALYST GuruFocus • 1d ago
Barclays Raises Fortrea (FTRE) Price Target to $26 Amid Stock Pr GuruFocus report covering Fortrea Holdings Inc. (FTRE) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Seeking Alpha • 1d ago
Fortrea Holdings Inc. 2026 Q3 - Results - Earnings Call Presentation (NASDAQ:FTRE) 2026-10-29 Seeking Alpha report covering Fortrea Holdings Inc. (FTRE) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE TradingView • 1d ago
Fortrea Holdings Inc. Estimates – NASDAQ:FTRE TradingView report covering Fortrea Holdings Inc. (FTRE) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Yahoo Finance • 1d ago
Fortrea Holdings (FTRE) Stock Sees Modest Fair Value Lift As Margin Views Improve Yahoo Finance report covering Fortrea Holdings Inc. (FTRE) market action, institutional positioning, and fundamental catalysts.
🔴 RISK WATCH Yahoo Finance • 1d ago
Fortrea (FTRE) Stock Drops After Q3 Results Lift Guidance Yahoo Finance report covering Fortrea Holdings Inc. (FTRE) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Yahoo Finance • 1d ago
Earnings to watch: Fortrea (FTRE) reports Q3 results tomorrow Yahoo Finance report covering Fortrea Holdings Inc. (FTRE) market action, institutional positioning, and fundamental catalysts.
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE
3 Active Posts & Replies
FTRE Bull vs. Bear Conversation Board — What's Your Call at $20.02?
🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON FTRE 🐻 33% BEARISH CONVICTION
MI MidwestValue RQD DEBATE OPENER • Fundamental Long-Only 🐂 BULLISH
🎯 Target: $24.48 (+15.0%)
📌 Pinned Debate Institutional whale/13F flow scores 17 / 20 and a Barclays price target was raised to $26 amid the recent rally.
Institutional whale/13F flow scores 17 / 20 and a Barclays price target was raised to $26 amid the recent rally.. When you look under the hood at FTRE, Fundamental Cash Engine is 4/20 with 0.0% gross margins and -35.0% ROIC. Bears are staring in the rearview mirror while institutional 13F flow (14/20) has been quietly accumulating below $26.16. My 12M target is $24.48.
RetailWhale_TX 🐂 BULL
Both sides have a point here — FTRE's 5/20 balance sheet score keeps downside contained, so the real swing factor next earnings call is backlog and FCF conversion.
ME MeanReversion_88 RQD DEBATE OPENER • Quantitative Statistical Arb 🐻 BEARISH
🎯 Target: $18.10 (-15.0%)
Spot @ $21.29 Negative operating income of -$872.6M, ROIC of -35%, and an Altman Z-Score of 0.45 point to weak cash generation and financial distress
Fading this rally in FTRE at $21.29. Negative operating income of -$872.6M, ROIC of -35%, and an Altman Z-Score of 0.45 point to weak cash generation and financial distress risk.. With a beta of 0.99 and the stock sitting at $21.29 (52-wk range $8.55–$26.16), the easy multiple expansion is already priced in.